IMCC

IM Cannabis Corp.

Price

$3.53

return (12m)

-94.93%

p/e

-2.46

p/bv

-7.92

DIVIDEND YIELD

0.00%

IMCC price

IM Cannabis

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IMCC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.49%

3 months

-59.14%

1 year

-94.93%

2 years

-95.29%

5 years

-99.94%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IMCC

Valuation

P/E

-2.46

Sector -0.08

Industry -3.75

P/BV

-7.92

Sector 1.94

Industry 1.33

P/Revenue (PSR)

0.96

Sector 1.67

Industry 2.28

EV/EBITDA

-45.06

Sector -56.00

Industry -38.63

EV/EBIT

-28.79

Sector -489.10

Industry -62.11

P/EBITDA

-3.69

Sector -178.66

Industry -39.80

P/EBIT

-3.14

Sector -214.49

Industry -59.07

P/Total Assets

1.81

Sector 0.92

Industry 0.86

P/Net Current Assets

-3.18

Sector -24.09

Industry -82.48

P/Working Capital

-3.41

Sector -5.16

Industry -6.79

EPS

-1.44

Sector -0.79

Industry -1.25

BVPS

-0.45

Sector 3.79

Industry 2.23

Efficiency

Gross Margin

12.47%

Sector 48.28%

Industry 49.22%

EBITDA Margin

-12.75%

Sector -5,407,515.68%

Industry -20,100,387.98%

EBIT Margin

-19.96%

Sector -62.93%

Industry -18,749,058.89%

Operating Margin

-33.12%

Sector -23.12%

Industry -30.01%

Net Profit Margins

-39.07%

Sector -27.40%

Industry -32.63%

Asset Turnover

0.31

Sector 0.13

Industry 0.06

Profitability

ROE

322.69%

Sector -30.97%

Industry -44.11%

ROA

-73.56%

Sector -28.25%

Industry -50.97%

ROIC

-28.52%

Sector -317.33%

Industry -162.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.56

Sector 1.85

Industry 2.38

Net Debt / EBITDA

0.99

Sector -42.46

Industry -15.77

Net Debt / EBIT

0.63

Sector -37.26

Industry -71.89

Net Debt / Equity

0.17

Sector -1.04

Industry -1.11

Gross Debt / Equity

-0.12

Sector -0.72

Industry -0.54

Equity/Assets

-0.23

Sector 0.43

Industry 0.49

Liabilities/Assets

1.23

Sector 0.48

Industry 0.44

Growth

5Y Revenue CAGR

1.90%

Sector -

Industry -

5Y Earnings CAGR

-1.60%

Sector -

Industry -

Fundamentals IMCC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IMCC IM Cannabis Corp.	$3.53	-94.79%	0.00%	-2.46	-7.92	322.69%	-39.07%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
SNY Sanofi	$44.84	-7.34%	3.94%	7.29	1.34	18.43%	13.81%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.49%	15.59	4.40	28.24%	14.54%
CRMD CorMedix Inc.	$8.22	-41.87%	0.00%	3.43	1.39	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$21.77	-28.60%	0.00%	12.19	1.25	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.12	-14.31%	0.69%	27.49	2.48	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.68	7.19	17.26%	28.62%
NVS Novartis AG	$153.04	22.95%	2.03%	27.32	7.50	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	32.86	4.36	13.26%	15.08%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.13%	24.33	2.33	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	16.90	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.17	6.20	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.35	27.10	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.01%	22.77	5.33	23.41%	27.44%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.93	2.89	7.61%	15.95%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.72%	11.79	-28.86	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	118.60	4.87	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.79%	19.71	1.93	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.62%	1.06%	33.72	5.24	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IMCC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IM Cannabis

IM Cannabis Corp.

Average Investor10 user rating

4.0 (1 people)

United States

46 years

Founded: 1980

2020

Time since IPO - 6 years

24

Employees

IM Cannabis Corp. (United States) is listed on the Nasdaq and has a market capitalization of $31.77 million, with shareholders equity totaling $-4.01 million.

The company employs approximately 24 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, IM Cannabis Corp. reported $33.12 million in revenue, generating net income of $-12.94 million.

Key financial metrics include a P/E ratio of -2.46, a price-to-book (P/B) ratio of -7.92, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IMCC.

Market cap

$31.77 million

Net worth

$-4.01 million

$-4,010,000.00

Assets

$17.59 million

$17,590,000.00

Total Shares Outstanding

9.00 million

9,000,000

Average Daily Trading Volume

$3.55 million

$3,553,132.12

Sector

Health

Industry

Pharmaceutical Products

IMCC

IMCC revenue and profits

Financial Results IMCC

DRAG THE FRAME TO SEE MORE DATA

IMCC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.84%

ROE

-178.93%

P/BV

1.50

CI - Cigna

$279.22 --5,15% (12M)

P/E

10.78

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.23

0.00%

ROE

-22.56%

P/BV

1.40

HUM - Humana

$390.51 30,46% (12M)

P/E

36.19

0.91%

ROE

6.72%

P/BV

2.43

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.29

3.94%

ROE

18.43%

P/BV

1.34

LLY - Eli Lilly

$1,169.97 60,27% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

11.79

0.72%

ROE

-244.72%

P/BV

-28.86

NVS - Novartis

$153.04 23,28% (12M)

P/E

27.32

2.03%

ROE

27.47%

P/BV

7.50